TIDMCOS

RNS Number : 5735Z

Collagen Solutions PLC

18 December 2017

December 18, 2017

Collagen Solutions Plc

(the "Company" or the "Group")

Collagen Solutions Strengthens Board with Non-Executive Appointment

Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen and tissue components for use in regenerative medicine applications including orthopaedics, dental, wounds, and cardiovascular is pleased to announce the appointment of Chris Brinsmead CBE to the Non-Executive Board.

Chris Brinsmead (58) has worked in the Pharmaceutical industry for over thirty years, holding executive leadership roles within ICI and AstraZeneca. He was President of the ABPI from 2008 to 2010. He is currently on the Board of UDG Healthcare plc and The Wesleyan Assurance Society, having previously held Board positions at Domino Printing Sciences plc, Cambian Group plc and Kinapse Ltd. He also chairs two private companies, Proveca Ltd and Bamburgh Capital Ltd. Chris is a Member of Council at Imperial College and an advisor and champion on Life Sciences for the UK Government. He was appointed a CBE in January 2015.

Chris Brinsmead holds a BSc in Civil Engineering from Nottingham University and an MSc in Business Science from Manchester Business School.

Commenting on this appointment, Jamal Rushdy, CEO of Collagen Solutions said: "We are delighted to have Chris join Collagen Solutions' Board at this pivotal time as we look to significantly expand our core business and launch exciting new proprietary products. His extensive and diverse executive and non-executive experience within the global life sciences arena, including leadership roles in the successful launch of commercial products, will strengthen our strategy and focus on execution for growth."

 
 Current Directorships       Previous Directorships 
--------------------------  -------------------------- 
 UDG Healthcare plc          Cambian Group Plc 
  The Wesleyan Assurance      Kinapse Limited 
  Society                     Domino Printing Sciences 
  Proveca Limited             Plc 
  Bamburgh Capital Limited 
  Datapharm Communications 
  Limited 
  CDB (Meadowside) Limited 
--------------------------  --------------------------

Chris Brinsmead holds 1,731,250 ordinary shares in the capital of the Company.

About Collagen Solutions:

Collagen Solutions Plc is a global provider of medical grade collagen formulations and components for use in regenerative medicine, medical devices and in-vitro diagnostics and research. The capabilities of the Company include the provision of native, soluble and powdered collagen formulations, processed and semi-processed tissues such as pericardium, bone, and blood vessels, and expertise in the development and contract manufacture of collagen components for use as engineered tissue scaffolds and other medical devices. These products are used in a wide variety of applications including orthopaedics, cardiovascular, dental, plastic surgery, wound healing, neurology and urology. Collagen Solutions' unique offering extends beyond material supply and contract services through the highly skilled staff who support customers through the various stages of development and regulatory approval. For additional information, please visit www.collagensolutions.com.

Enquiries:

 
 
   Collagen Solutions Plc 
 Jamal Rushdy, Chief Executive                                                           Via Walbrook 
  Officer 
 Gill Black, Chief Financial 
  Officer                                   Tel: 07721 413 496 or lisa.baderoon@collagensolutions.com 
  Lisa Baderoon, Head 
  of Investor Relations 
 
 Cenkos Securities plc (Nominated                                                  Tel: 0207 397 8900 
  Adviser and Broker) 
  Stephen Keys 
  Steve Cox 
 
 Walbrook PR                             Tel: 020 7933 8780 or 
                                          collagen@walbrookpr.com 
 Mike Wort                                                                         Mob: 07900 608 002 
 Anna Dunphy                                                                       Mob: 07876 741 001

This information is provided by RNS

The company news service from the London Stock Exchange

END

BOALLFFDFVLRLID

(END) Dow Jones Newswires

December 18, 2017 02:00 ET (07:00 GMT)

Collagen Solutions (LSE:COS)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Collagen Solutions Charts.
Collagen Solutions (LSE:COS)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Collagen Solutions Charts.